Endogenous regulation of cardiovascular function by apelin-APJ

被引:164
作者
Charo, David N.
Ho, Michael
Fajardo, Giovanni [2 ]
Kawana, Masataka
Kundu, Ramendra K.
Sheikh, Ahmad Y. [3 ]
Finsterbach, Thomas P.
Leeper, Nicholas J.
Ernst, Kavita V.
Chen, Mary M.
Ho, Yen Dong
Chun, Hyung J.
Bernstein, Daniel [2 ]
Ashley, Euan A.
Quertermous, Thomas [1 ]
机构
[1] Stanford Univ, Falk CVRC, Dept Med Cardiovasc Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat Cardiol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2009年 / 297卷 / 05期
基金
美国国家卫生研究院;
关键词
pressure-volume hemodynamics; cardiomyocyte; ORPHAN RECEPTOR; PEPTIDE LIGAND; BLOOD-PRESSURE; HEART-FAILURE; CONTRACTILITY; MOUSE; LOCALIZATION; MYOCYTES; MODELS; SYSTEM;
D O I
10.1152/ajpheart.00686.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T. Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol 297: H1904-H1913, 2009. First published September 18, 2009; doi:10.1152/ajpheart.00686.2009.-Studies have shown significant cardiovascular effects of exogenous apelin administration, including the potent activation of cardiac contraction. However, the role of the endogenous apelin-APJ pathway is less clear. To study the loss of endogenous apelin-APJ signaling, we generated mice lacking either the ligand (apelin) or the receptor (APJ). Apelin-deficient mice were viable, fertile, and showed normal development. In contrast, APJ-deficient mice were not born in the expected Mendelian ratio, and many showed cardiovascular developmental defects. Under basal conditions, both apelin and APJ null mice that survived to adulthood manifested modest decrements in contractile function. However, with exercise stress both mutant lines demonstrated consistent and striking decreases in exercise capacity. To explain these findings, we explored the role of autocrine signaling in vitro using field stimulation of isolated left ventricular cardiomyocytes lacking either apelin or APJ. Both groups manifested less sarcomeric shortening and impaired velocity of contraction and relaxation with no difference in calcium transient. Taken together, these results demonstrate that endogenous apelin-APJ signaling plays a modest role in maintaining basal cardiac function in adult mice with a more substantive role during conditions of stress. In addition, an autocrine pathway seems to exist in myocardial cells, the ablation of which reduces cellular contraction without change in calcium transient. Finally, differences in the developmental phenotype between apelin and APJ null mice suggest the possibility of undiscovered APJ ligands or ligand-independent effects of APJ.
引用
收藏
页码:H1904 / H1913
页数:10
相关论文
共 38 条
[1]   The angiotensin II AT2 receptor is an AT1 receptor antagonist [J].
AbdAlla, S ;
Lother, H ;
Abdel-tawab, AM ;
Quitterer, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (43) :39721-39726
[2]   AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration [J].
AbdAlla, S ;
Lother, H ;
Quitterer, U .
NATURE, 2000, 407 (6800) :94-98
[3]   The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo [J].
Ashley, EA ;
Powers, J ;
Chen, M ;
Kundu, R ;
Finsterbach, T ;
Caffarelli, A ;
Deng, A ;
Eichhorn, J ;
Mahajan, R ;
Agrawal, R ;
Greve, J ;
Robbins, R ;
Patterson, AJ ;
Bernstein, D ;
Quertermous, T .
CARDIOVASCULAR RESEARCH, 2005, 65 (01) :73-82
[4]   Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression [J].
Atluri, Pavan ;
Morine, Kevin J. ;
Liao, George P. ;
Panlilio, Corinna M. ;
Berry, Mark F. ;
Hsu, Vivian M. ;
Hiesinger, William ;
Cohen, Jeffrey E. ;
Woo, Y. Joseph .
CELLULAR & MOLECULAR BIOLOGY LETTERS, 2007, 12 (01) :127-138
[5]   Apelin has in vivo inotropic effects on normal and failing hearts [J].
Berry, MF ;
Pirolli, TJ ;
Jayasankar, V ;
Burdick, J ;
Morine, KJ ;
Gardner, TJ ;
Woo, YJ .
CIRCULATION, 2004, 110 (11) :II187-II193
[6]   Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction [J].
Chen, MM ;
Ashley, EA ;
Deng, DXF ;
Tsalenko, A ;
Deng, A ;
Tabibiazar, R ;
Ben-Dor, A ;
Fenster, B ;
Yang, E ;
King, JY ;
Fowler, M ;
Robbins, R ;
Johnson, FL ;
Bruhn, L ;
McDonagh, T ;
Dargie, H ;
Yakhini, Z ;
Tsao, PS ;
Quertermous, T .
CIRCULATION, 2003, 108 (12) :1432-1439
[7]   Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats [J].
Cheng, X ;
Cheng, XS ;
Pang, CCY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 470 (03) :171-175
[8]   Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis [J].
Chun, Hyung J. ;
Ali, Ziad A. ;
Kojima, Yoko ;
Kundu, Ramendra K. ;
Sheikh, Ahmad Y. ;
Agrawal, Rani ;
Zheng, Lixin ;
Leeper, Nicholas J. ;
Pearl, Nathan E. ;
Patterson, Andrew J. ;
Anderson, Joshua P. ;
Tsao, Philip S. ;
Lenardo, Michael J. ;
Ashley, Euan A. ;
Quertermous, Thomas .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (10) :3343-3354
[9]   Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release [J].
De Mota, N ;
Goazigo, ARL ;
El Messari, S ;
Chartrel, N ;
Roesch, D ;
Dujardin, C ;
Kordon, C ;
Vaudry, H ;
Moos, FO ;
Llorens-Cortes, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (28) :10464-10469
[10]   Cardiovascular indexes in the mouse at rest and with exercise: New tools to study models of cardiac disease [J].
Desai, KH ;
Sato, R ;
Schauble, E ;
Barsh, GS ;
Kobilka, BK ;
Bernstein, D .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (02) :H1053-H1061